Annual Accounts Payable
N/A
December 1, 2024
Summary
- PFE annual accounts payable is not available.
Performance
PFE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
December 1, 2024
Summary
- PFE quarterly accounts payable is not available.
Performance
PFE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PFE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.31 B(+4.1%) |
| Jun 2024 | - | $5.11 B(-8.7%) |
| Mar 2024 | - | $5.59 B(-16.7%) |
| Dec 2023 | $6.71 B(-1.5%) | $6.71 B(+25.7%) |
| Sep 2023 | - | $5.34 B(-12.2%) |
| Jun 2023 | - | $6.08 B(-0.7%) |
| Mar 2023 | - | $6.12 B(-10.1%) |
| Dec 2022 | $6.81 B(+22.1%) | $6.81 B(+8.6%) |
| Sep 2022 | - | $6.27 B(+1.0%) |
| Jun 2022 | - | $6.21 B(+12.7%) |
| Mar 2022 | - | $5.51 B(-1.3%) |
| Dec 2021 | $5.58 B(+30.2%) | $5.58 B(+18.7%) |
| Sep 2021 | - | $4.70 B(+8.6%) |
| Jun 2021 | - | $4.33 B(+6.5%) |
| Mar 2021 | - | $4.06 B(-5.1%) |
| Dec 2020 | $4.28 B(+10.2%) | $4.28 B(+3.4%) |
| Sep 2020 | - | $4.14 B(+6.9%) |
| Jun 2020 | - | $3.87 B(-2.5%) |
| Mar 2020 | - | $3.97 B(+2.2%) |
| Dec 2019 | $3.89 B(-16.8%) | $3.89 B(-1.4%) |
| Sep 2019 | - | $3.94 B(-1.5%) |
| Jun 2019 | - | $4.00 B(-3.7%) |
| Mar 2019 | - | $4.16 B(-11.1%) |
| Dec 2018 | $4.67 B(+0.4%) | $4.67 B(+8.8%) |
| Sep 2018 | - | $4.30 B(+2.4%) |
| Jun 2018 | - | $4.20 B(+8.2%) |
| Mar 2018 | - | $3.88 B(-16.7%) |
| Dec 2017 | $4.66 B(+2.6%) | $4.66 B(+33.8%) |
| Sep 2017 | - | $3.48 B(+1.2%) |
| Jun 2017 | - | $3.44 B(+1.4%) |
| Mar 2017 | - | $3.39 B(-25.2%) |
| Dec 2016 | $4.54 B(+25.3%) | $4.54 B(+30.5%) |
| Sep 2016 | - | $3.48 B(+6.6%) |
| Jun 2016 | - | $3.26 B(+4.4%) |
| Mar 2016 | - | $3.13 B(-13.7%) |
| Dec 2015 | $3.62 B(+12.8%) | $3.62 B(+9.9%) |
| Sep 2015 | - | $3.29 B(+12.4%) |
| Jun 2015 | - | $2.93 B(+7.6%) |
| Mar 2015 | - | $2.72 B(-15.1%) |
| Dec 2014 | $3.21 B(-0.7%) | $3.21 B(+8.0%) |
| Sep 2014 | - | $2.97 B(-0.6%) |
| Jun 2014 | - | $2.99 B(+17.4%) |
| Mar 2014 | - | $2.55 B(-21.3%) |
| Dec 2013 | $3.23 B(+10.7%) | $3.23 B(+41.4%) |
| Sep 2013 | - | $2.29 B(+15.6%) |
| Jun 2013 | - | $1.98 B(-39.7%) |
| Mar 2013 | - | $3.28 B(+12.3%) |
| Dec 2012 | $2.92 B(-20.6%) | $2.92 B(-1.6%) |
| Sep 2012 | - | $2.97 B(-6.3%) |
| Jun 2012 | - | $3.17 B(+2.4%) |
| Mar 2012 | - | $3.09 B(-16.0%) |
| Dec 2011 | $3.68 B(-8.6%) | $3.68 B(-2.3%) |
| Sep 2011 | - | $3.77 B(+1.8%) |
| Jun 2011 | - | $3.70 B(-1.4%) |
| Mar 2011 | - | $3.75 B(-6.9%) |
| Dec 2010 | $4.03 B(-7.9%) | $4.03 B(+25.6%) |
| Sep 2010 | - | $3.21 B(+4.2%) |
| Jun 2010 | - | $3.08 B(+1.7%) |
| Mar 2010 | - | $3.03 B(-30.7%) |
| Dec 2009 | $4.37 B(+149.6%) | $4.37 B(+76.1%) |
| Sep 2009 | - | $2.48 B(-4.4%) |
| Jun 2009 | - | $2.60 B(+65.0%) |
| Mar 2009 | - | $1.57 B(-10.2%) |
| Dec 2008 | $1.75 B(-22.9%) | $1.75 B(+6.2%) |
| Sep 2008 | - | $1.65 B(-14.5%) |
| Jun 2008 | - | $1.93 B(+1.0%) |
| Mar 2008 | - | $1.91 B(-15.9%) |
| Dec 2007 | $2.27 B | $2.27 B(-1.2%) |
| Sep 2007 | - | $2.30 B(+24.6%) |
| Jun 2007 | - | $1.84 B(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $2.04 B(+0.9%) |
| Dec 2006 | $2.02 B(-2.6%) | $2.02 B(+15.9%) |
| Sep 2006 | - | $1.74 B(+0.1%) |
| Jun 2006 | - | $1.74 B(-8.0%) |
| Mar 2006 | - | $1.89 B(-8.7%) |
| Dec 2005 | $2.07 B(-22.4%) | $2.07 B(+14.6%) |
| Sep 2005 | - | $1.81 B(-13.9%) |
| Jun 2005 | - | $2.10 B(-8.7%) |
| Mar 2005 | - | $2.30 B(-13.9%) |
| Dec 2004 | $2.67 B(+3.3%) | $2.67 B(+14.7%) |
| Sep 2004 | - | $2.33 B(-6.1%) |
| Jun 2004 | - | $2.48 B(+0.0%) |
| Mar 2004 | - | $2.48 B(-4.2%) |
| Dec 2003 | $2.59 B(+59.7%) | $2.59 B(+29.5%) |
| Sep 2003 | - | $2.00 B(-5.8%) |
| Jun 2003 | - | $2.12 B(+54.4%) |
| Mar 2003 | - | $1.37 B(-15.2%) |
| Dec 2002 | $1.62 B(+14.8%) | $1.62 B(+4.4%) |
| Sep 2002 | - | $1.55 B(+1.8%) |
| Jun 2002 | - | $1.52 B(-4.2%) |
| Mar 2002 | - | $1.59 B(+12.8%) |
| Dec 2001 | $1.41 B(-17.9%) | $1.41 B(-13.5%) |
| Sep 2001 | - | $1.63 B(+5.8%) |
| Jun 2001 | - | $1.54 B(+8.7%) |
| Mar 2001 | - | $1.42 B(-17.5%) |
| Dec 2000 | $1.72 B(-9.0%) | $1.72 B(+21.3%) |
| Sep 2000 | - | $1.42 B(-1.6%) |
| Jun 2000 | - | $1.44 B(+68.4%) |
| Mar 2000 | - | $855.00 M(-54.7%) |
| Dec 1999 | $1.89 B(+94.5%) | $1.89 B(+172.2%) |
| Sep 1999 | - | $694.00 M(-9.9%) |
| Jun 1999 | - | $770.00 M(+17.4%) |
| Mar 1999 | - | $656.00 M(-32.4%) |
| Dec 1998 | $971.00 M(+47.1%) | $971.00 M(+18.8%) |
| Sep 1998 | - | $817.00 M(+0.4%) |
| Jun 1998 | - | $814.00 M(+12.4%) |
| Mar 1998 | - | $724.00 M(+9.7%) |
| Dec 1997 | $660.00 M(-27.7%) | $660.00 M(-6.0%) |
| Sep 1997 | - | $702.00 M(-27.7%) |
| Jun 1997 | - | $971.00 M(+18.6%) |
| Mar 1997 | - | $819.00 M(-10.3%) |
| Dec 1996 | $913.00 M(+27.6%) | $913.00 M(+21.7%) |
| Sep 1996 | - | $750.00 M(+15.0%) |
| Jun 1996 | - | $652.00 M(+8.3%) |
| Mar 1996 | - | $602.00 M(-15.8%) |
| Dec 1995 | $715.30 M(+36.3%) | $715.30 M(+12.5%) |
| Sep 1995 | - | $636.00 M(-11.1%) |
| Jun 1995 | - | $715.10 M(+24.8%) |
| Mar 1995 | - | $573.20 M(+9.2%) |
| Dec 1994 | $524.90 M(+9.6%) | $524.90 M(+21.3%) |
| Sep 1994 | - | $432.90 M(+1.4%) |
| Jun 1994 | - | $427.10 M(-4.9%) |
| Mar 1994 | - | $449.00 M(-6.3%) |
| Dec 1993 | $479.10 M(+5.0%) | $479.10 M(+21.4%) |
| Sep 1993 | - | $394.60 M(+2.7%) |
| Jun 1993 | - | $384.30 M(+0.8%) |
| Mar 1993 | - | $381.30 M(-16.5%) |
| Dec 1992 | $456.40 M(-1.4%) | $456.40 M(+4.3%) |
| Sep 1992 | - | $437.40 M(-2.0%) |
| Jun 1992 | - | $446.10 M(+1.3%) |
| Mar 1992 | - | $440.20 M(-4.9%) |
| Dec 1991 | $462.90 M(+2.8%) | $462.90 M(+15.4%) |
| Sep 1991 | - | $401.30 M(-2.4%) |
| Jun 1991 | - | $411.00 M(-3.8%) |
| Mar 1991 | - | $427.40 M(-5.1%) |
| Dec 1990 | $450.30 M(+12.2%) | $450.30 M(+7.7%) |
| Sep 1990 | - | $418.00 M(+10.3%) |
| Jun 1990 | - | $379.00 M(+2.2%) |
| Mar 1990 | - | $370.90 M(-7.6%) |
| Dec 1989 | $401.40 M | $401.40 M |
FAQ
- What is the all time high annual accounts payable for Pfizer?
- What is the all time high quarterly accounts payable for Pfizer?
What is the all time high annual accounts payable for Pfizer?
Pfizer all-time high annual accounts payable is $6.81 B
What is the all time high quarterly accounts payable for Pfizer?
Pfizer all-time high quarterly accounts payable is $6.81 B